Skip to main content
. 2014 Aug 7;2:90. doi: 10.1186/s40478-014-0090-1

Figure 7.

Figure 7

Quantification of Iba1 immunoreactivity (IR) in the substantia nigra (SN) and hippocampal CA2 region of control subjects, iLBD cases and PD patients. (a) A significant increase was present in Iba1 IR in the SN of PD patients relative to control subjects (*p < 0.05 vs Ctr); (b) no significant difference was present in the CA2. Data represent mean ± SEM.